Capital Savings Fund
Earn 10% On Your Equity

Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Announces Move Toward Regulatory Submission Following Initial Data From LUCIDITY Trial

Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Announces Move Toward Regulatory Submission Following Initial Data From LUCIDITY Trial

31 May    Finance News

Investor and Media Relations
T: (416) 864-3584
E: ir@dundeecorporation.com Read More

See also  Abitibi Metals to Present at the Clean Energy Metals Virtual Investor Conference August 29th
Avatar photo

ByCapitalGainsFund

Leave a Reply

Your email address will not be published. Required fields are marked *